Mid-regional pro-adrenomedullin as a marker for sepsis prognosis
Author Information
Author(s): Christ-Crain Mirjam, Morgenthaler Nils G, Struck Joachim, Harbarth Stephan, Bergmann Andreas, Müller Beat
Primary Institution: University Hospital Basel
Hypothesis
The study aims to evaluate the prognostic value of mid-regional pro-adrenomedullin (MR-proADM) levels in critically ill patients with sepsis.
Conclusion
MR-proADM may be helpful in individual risk assessment in septic patients.
Supporting Evidence
- MR-proADM levels were significantly higher in nonsurvivors than in survivors.
- The area under the curve for MR-proADM was 0.81, indicating good prognostic accuracy.
- Median MR-proADM levels increased with the severity of sepsis.
Takeaway
Doctors can use a blood test for MR-proADM to help figure out how sick a patient with sepsis is and if they might survive.
Methodology
The study evaluated blood samples from 101 critically ill patients and 160 healthy controls, measuring MR-proADM levels using a sandwich immunoassay.
Limitations
The generalizability of the findings is limited due to the small number of septic patients included.
Participant Demographics
The mean age of patients was 57 years, with 55 men and 46 women.
Statistical Information
P-Value
<0.001
Confidence Interval
95% confidence interval 0.63–0.99
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website